Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.

Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.

High-dose valaciclovir at up to 8 g/day has been shown to be effective in prophylaxis against cytomegalovirus (CMV) disease in renal transplant recipients. We report our experience with low-dose valaciclovir prophylaxis of up to 3 g/day, adjusted to creatinine clearance. A group of patients at high...

書誌詳細
主要な著者:	Reddy, S, Handa, A, Tan, L, Devaney, A, Hughes, D, Mason, P, Friend, P, Darby, C
フォーマット:	Journal article
言語:	English
出版事項:	2003

類似資料

Comparison between valganciclovir and aciclovir/valaciclovir for CMV prophylaxis in pediatric renal transplantation
著者:: M Fila, 等
出版事項: (2015-01-01)

Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
著者:: Allan S MacDonald, 等
出版事項: (1993-01-01)

Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.
著者:: Hughes, D, 等
出版事項: (2008)

Resistant cytomegalovirus infection in renal transplant recipients
著者:: Benjamin Pei Zhi Cherng, 等
出版事項: (2015-12-01)

Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
著者:: Currie, A, 等
出版事項: (2010)

Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy
著者:: Giovanni Nigro, 等
出版事項: (2023-06-01)

Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
著者:: Linda A. Selvey, 等
出版事項: (2017-07-01)

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
著者:: Woo Yeong Park, 等
出版事項: (2020-03-01)

Coinfection of BK virus and cytomegalovirus in renal transplant recipients
著者:: Rudreshwar Prabakaran, 等
出版事項: (2017-01-01)

Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients
著者:: Nathalie Hammer, 等
出版事項: (2024-05-01)

Lymphocyte subpopulations during cytomegalovirus disease in renal transplant recipients
著者:: S.M. Castro, 等
出版事項: (2003-06-01)

Cytomegalovirus disease in a renal transplant recipient: the importance of pre-transplant screening of the donor and recipient
著者:: Ahmed H Mitwalli, 等
出版事項: (2013-01-01)

A single-centre observational study comparing the impact of different cytomegalovirus prophylaxis strategies on cytomegalovirus infections in kidney transplant recipients
著者:: Mabel Si Hua Tan, 等
出版事項: (2021-06-01)

The incidence of cytomegalovirus infection in lung transplant recipients under universal prophylaxis with intravenous ganciclovir
著者:: Regina Schröeder, 等

Cytomegalovirus infection in renal transplant recipients diagnosed by nested-PCR
著者:: V.H. Aquino, 等
出版事項: (2001-01-01)

Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab
著者:: Jorge Andrade-Sierra, 等
出版事項: (2021-06-01)

Rabdomiolisis asociada al tratamiento con valaciclovir
著者:: Héctor Enríquez Gómez, 等
出版事項: (2012-03-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
著者:: Ümit Özçelik, 等
出版事項: (2020-01-01)

Cytomegalovirus infection in transplant recipients
著者:: Luiz Sergio Azevedo, 等
出版事項: (2015-07-01)

Molecular detection and genotyping of Human Cytomegalovirus in kidney transplant recipients under ganciclovir prophylaxis in Iran
著者:: Farzane Behnezhad, 等
出版事項: (2022-07-01)

PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS
著者:: V. V. Ryazhenov, 等
出版事項: (2011-06-01)

Cytomegalovirus ischemic colitis and transverse myelitis in a renal transplant recipient
著者:: Imen Gorsane, 等
出版事項: (2013-01-01)

Evaluation of diagnostic tests for cytomegalovirus active infection in renal transplant recipients
著者:: Rodrigo Fontanive Franco, 等

Cytomegalovirus Infection in Pediatric Renal Transplant Recipients: A Single Center Experience
著者:: Mi Jin Kim, 等
出版事項: (2017-10-01)

Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
著者:: Diana D. Wong, 等
出版事項: (2022-06-01)

Cytomegalovirus Infection in Kidney Transplant Recipients
著者:: Dino Šisl, 等
出版事項: (2021-04-01)

Cytomegalovirus DNAemia in kidney transplant recipients after cessation of standard antiviral prophylaxis; estimated rate on Thai cases and implication on efficacy of prophylaxis
著者:: Won Sriwijitalai, 等
出版事項: (2019-05-01)

Direct visualisation of cytomegalovirus-specific CD8+ T cells in renal transplant recipients.
著者:: Hilton, R, 等
出版事項: (2002)

Cytomegalovirus infection and unusual early graft dysfunction in a renal transplant recipient
著者:: Suzan Sanavi, 等
出版事項: (2009-01-01)

Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy
著者:: Anupma Kaul, 等
出版事項: (2018-01-01)

Postsurgical skin ulcers caused by cytomegalovirus vasculopathy in a renal transplant recipient
著者:: Shikha Rao, MD, 等
出版事項: (2020-07-01)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
著者:: Lally, A, 等
出版事項: (2006)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
著者:: Restelli U, 等
出版事項: (2019-05-01)

Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab
著者:: Zahir Amoura, 等
出版事項: (2025-01-01)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
著者:: Susanne Jung, 等
出版事項: (2019-05-01)

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
著者:: Kaiwen Chen, 等
出版事項: (2018-08-01)

Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy
著者:: Camilo Montero, 等
出版事項: (2023-03-01)

Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy
著者:: Camilo Montero, 等
出版事項: (2023-03-01)

Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients
著者:: Jutta K Preiksatis
出版事項: (1993-01-01)

Comparison of prophylactic versus preemptive treatments in the management of cytomegalovirus infection in renal transplant recipients
著者:: Cengiz Karaçin, 等
出版事項: (2020-05-01)